Sociedad Española de Medicina de Laboratorio (SEQCML), Laboratorio de Bioquímica Clínica, Hospital Universitario Virgen Macarena de Sevilla, Sevilla, España. Investigador Asociado, Facultad de Ciencias de la Salud, Universidad Autónoma de Chile, Santiago de Chile, Chile.
Sociedad Española de Arteriosclerosis (SEA), Unidad de Medicina Interna, Hospital Universitario Fundación de Alcorcón, Universidad Rey Juan Carlos, Madrid, España.
Clin Investig Arterioscler. 2023 Mar-Apr;35(2):91-100. doi: 10.1016/j.arteri.2022.10.002. Epub 2023 Mar 14.
Cardiovascular diseases (CVD) continue to be the main cause of death in our country. Adequate control of lipid metabolism disorders is a key challenge in cardiovascular prevention that is far from being achieved in real clinical practice. There is a great heterogeneity in the reports of lipid metabolism from Spanish clinical laboratories, which may contribute to its poor control. For this reason, a working group of the main scientific societies involved in the care of patients at vascular risk, has prepared this document with a consensus proposal on the determination of the basic lipid profile in cardiovascular prevention, recommendations for its realization and unification of criteria to incorporate the lipid control goals appropriate to the vascular risk of the patients in the laboratory reports.
心血管疾病(CVD)仍然是我国主要的死亡原因。充分控制脂质代谢紊乱是心血管预防的关键挑战,但在实际临床实践中远未实现。西班牙临床实验室的脂质代谢报告存在很大的异质性,这可能导致其控制不佳。出于这个原因,一个由主要科学协会的工作组参与血管风险患者护理,已经制定了这份文件,提出了关于在心血管预防中确定基本脂质谱的共识建议,实现该建议的建议,并统一标准,将适当的血管风险患者的脂质控制目标纳入实验室报告。